Evidence map›Paper›PMID 40615808›Full record

ArticleBMC pulmonary medicine2025

The effects of different follow-up management on asthma control: a prospective cohort study.

Zhi Lu, Hongzhong Yang, Muyun Yan, Jun Liu, Lu Yang, Caixia Zhang, Da Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhi LuDepartment of Pulmonary and Critical Care Medicine, Hengyang Medical School, The Affiliated Changsha Central Hospital, University of South China, Changsha, Hunan, 410004, China.
Hongzhong YangDepartment of Pulmonary and Critical Care Medicine, Hengyang Medical School, The Affiliated Changsha Central Hospital, University of South China, Changsha, Hunan, 410004, China.
Muyun YanDepartment of Pulmonary and Critical Care Medicine, Hengyang Medical School, The Affiliated Changsha Central Hospital, University of South China, Changsha, Hunan, 410004, China.
Jun LiuDepartment of Pulmonary and Critical Care Medicine, Hengyang Medical School, The Affiliated Changsha Central Hospital, University of South China, Changsha, Hunan, 410004, China.
Lu YangDepartment of Pulmonary and Critical Care Medicine, Hengyang Medical School, The Affiliated Changsha Central Hospital, University of South China, Changsha, Hunan, 410004, China.
Caixia ZhangDepartment of Pulmonary and Critical Care Medicine, Hengyang Medical School, The Affiliated Changsha Central Hospital, University of South China, Changsha, Hunan, 410004, China.
Da LiuDepartment of Pulmonary and Critical Care Medicine, Hengyang Medical School, The Affiliated Changsha Central Hospital, University of South China, Changsha, Hunan, 410004, China. 2018050679@usc.edu.cn.

Funding

National Natural Science Foundation of China 82300042
6 · The paper itself

Abstract

backgroundAsthma is a chronic inflammatory disease of the airways. Proper use of inhaled medications and long-term standardized management are crucial for controlling asthma. In China, the morbidity of asthma among adults aged 20 and above is 4.2%, of which only 28.5% has been controlled.

objectiveThis study aims to find the best model for long-term standardized asthma management by analyzing the effects of three follow-up methods: respiratory outpatient clinics follow-up, telephone follow-up, and WeChat follow-up on overall asthma control and patient medication compliance.

methodsAccording to different follow-up methods, asthma patients were divided into a WeChat follow-up group (N = 140), a telephone follow-up group (N = 140), and an respiratory outpatient clinics follow-up group (N = 140), the three groups of patients underwent 12 months follow-up management. Outcomes were measured at baseline and after 1, 6, and 12 months of the intervention. The results of the assessment included the Medication Adherence Report Scale for Asthma (MARS-A), the Asthma Quality of Life Questionnaire (AQLQ), the Asthma Control Test Questionnaire (ACT), the satisfaction scale, the Beck Depression Inventory-II (BDI-II), the Global evaluation of treatment effectiveness (GETE), hospitalization, and emergency visits.

resultsRepeated measures analysis of variance showed that there were group effects and time effects on total MARS-A, ACT, BDI-II, GETE, and AQLQ in three groups (P < 0.001). Comparing the scores at the different times among the three groups, the results showed that the MARS-A, ACT, and AQLQ scores of the WeChat follow-up group were higher than those of the telephone follow-up group and the respiratory outpatient clinic follow-up group at 6 and 12 months after follow-up. In comparison, the BDI-II and GETE scores were lower than those of the telephone follow-up group and the respiratory outpatient clinic follow-up group (P < 0.05).

conclusionOur results demonstrate that all three follow-up methods improved asthma control, alleviate depression, and improve patient medication compliance, satisfaction, treatment effectiveness, and quality of life. However, the effect of the WeChat follow-up group is better than telephone follow-up and respiratory outpatient follow-up groups. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Anti-Asthmatic AgentsAsthmaAdultChinaFemaleFollow-Up StudiesHumansMaleMedication AdherenceMiddle AgedPatient SatisfactionProspective StudiesQuality of LifeSurveys and QuestionnairesTelephoneYoung AdultAnti-Asthmatic AgentsAdultsAsthmaFollow-up managementMedication complianceQuality of lifeTelemedicine

Identifiers

PMID40615808
PMCPMC12228337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.